CA2732294A1 - Accelerated therapy - Google Patents

Accelerated therapy Download PDF

Info

Publication number
CA2732294A1
CA2732294A1 CA2732294A CA2732294A CA2732294A1 CA 2732294 A1 CA2732294 A1 CA 2732294A1 CA 2732294 A CA2732294 A CA 2732294A CA 2732294 A CA2732294 A CA 2732294A CA 2732294 A1 CA2732294 A1 CA 2732294A1
Authority
CA
Canada
Prior art keywords
romidepsin
cancer
leu
approximately
time period
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2732294A
Other languages
English (en)
French (fr)
Inventor
William Mcculloch
Henry Miles Prince
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Peter Maccallum Cancer Centre
Original Assignee
Peter Maccallum Cancer Centre
Gloucester Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter Maccallum Cancer Centre, Gloucester Pharmaceuticals LLC filed Critical Peter Maccallum Cancer Centre
Publication of CA2732294A1 publication Critical patent/CA2732294A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2732294A 2008-07-30 2009-07-30 Accelerated therapy Abandoned CA2732294A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8479708P 2008-07-30 2008-07-30
US61/084,797 2008-07-30
PCT/US2009/052269 WO2010014819A1 (en) 2008-07-30 2009-07-30 Accelerated therapy

Publications (1)

Publication Number Publication Date
CA2732294A1 true CA2732294A1 (en) 2010-02-04

Family

ID=41610730

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2732294A Abandoned CA2732294A1 (en) 2008-07-30 2009-07-30 Accelerated therapy

Country Status (6)

Country Link
US (1) US20100152100A1 (https=)
EP (1) EP2309854A4 (https=)
JP (1) JP2011529904A (https=)
CA (1) CA2732294A1 (https=)
MX (1) MX2011001132A (https=)
WO (1) WO2010014819A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101687010A (zh) * 2006-12-29 2010-03-31 格洛斯特制药公司 制备Romidepsin
AU2007342028B2 (en) 2006-12-29 2013-06-13 Celgene Corporation Purifiction of romidepsin
BR112013004714A2 (pt) * 2010-09-01 2016-05-17 Novartis Ag "combinações de inibidores de hdac com fármacos de trombocitopenia e seus usos"
US8859502B2 (en) * 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
ES2750308T3 (es) 2015-05-22 2020-03-25 Bioiberica Proceso para preparar un extracto de cerebro de un animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2012801A4 (en) * 2006-04-24 2009-08-05 Gloucester Pharmaceuticals Inc GEMCITABINE COMBINATION THERAPY
JP2009539862A (ja) * 2006-06-09 2009-11-19 メリオン リサーチ Ｉｉｉ リミテッド 強化剤を含む固体経口投与剤形

Also Published As

Publication number Publication date
WO2010014819A1 (en) 2010-02-04
US20100152100A1 (en) 2010-06-17
JP2011529904A (ja) 2011-12-15
MX2011001132A (es) 2011-08-17
EP2309854A4 (en) 2012-06-06
EP2309854A1 (en) 2011-04-20

Similar Documents

Publication Publication Date Title
US9259452B2 (en) Deacetylase inhibitor therapy
US9624271B2 (en) Romidepsin solid forms and uses thereof
US20120302520A1 (en) Gemcitabine combination therapy
EP2156846A1 (en) Prophylactic or therapeutic agent for diarrhea
US20100152100A1 (en) Accelerated therapy
US20160367625A1 (en) Romidepsin formulations and uses thereof
Michelinaki et al. Aminoacyl and peptidyl analogs of chloramphenicol as slow-binding inhibitors of ribosomal peptidyltransferase: a new approach for evaluating their potency
AU2020298031B2 (en) Succinate prodrug, compositions containing the succinate prodrug and uses thereof
WO2019173159A1 (en) Ergothioneine compositions and methods for maintaining and/or increasing vitamin c levels in cells and organisms
AU2015202335B2 (en) Romidepsin solid forms and uses thereof
CN115279339A (zh) 稳定的无环糊精的卡非佐米配制品

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140730